BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17079526)

  • 1. A safety review of long-acting beta2-agonists in patients with asthma.
    Rider NL; Craig TJ
    J Am Osteopath Assoc; 2006 Sep; 106(9):562-7. PubMed ID: 17079526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of long-acting beta2-agonists in the treatment of asthma.
    Cazzola M; Matera MG
    Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of preventive treatment with long-acting beta(2)-adrenergic agonists and inhaled corticosteroids on the morbidity and mortality of severe asthma exacerbations in 1543 patients].
    Plaza V; Bellido-Casado J; Rodrigo GJ; Solarte I; Rodríguez-Trigo G; Sepúlveda R; Neffen H; Perpiñá M
    Arch Bronconeumol; 2009 Nov; 45(11):545-9. PubMed ID: 19651467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the safety of long-acting beta-agonists in combination with inhaled corticosteroids for the treatment of asthma.
    Nelson HS; Carr W; Nathan R; Portnoy JM
    Ann Allergy Asthma Immunol; 2009 Jan; 102(1):11-5. PubMed ID: 19205279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
    Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
    J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
    Gibson PG; Powell H; Ducharme FM
    J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
    Rowe BH; Wong E; Blitz S; Diner B; Mackey D; Ross S; Senthilselvan A
    Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Caution recommended in prescribing long-acting beta2-adrenergic agonists to patients with asthma].
    Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2006 Apr; 150(16):889-91. PubMed ID: 16686087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is new with the beta2-agonists: issues in the management of asthma.
    Kelly HW
    Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting beta2-adrenoceptor agonists: a smart choice for asthma?
    Lipworth BJ
    Trends Pharmacol Sci; 2007 Jun; 28(6):257-62. PubMed ID: 17466387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of combined treatment with corticosteroids and beta2 agonists in adults with asthma].
    ten Hacken NH; Kerstjens HA; Postma DS
    Ned Tijdschr Geneeskd; 2006 Apr; 150(16):892-7. PubMed ID: 16686088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The addition of long-acting beta-agonists to inhaled corticosteroids in asthma.
    Sears MR
    Curr Opin Pulm Med; 2011 Jan; 17(1):23-8. PubMed ID: 21045700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long acting beta agonists.
    Bowler S
    Aust Fam Physician; 1998 Dec; 27(12):1115-8. PubMed ID: 9919735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary therapy in asthma: inhaled corticosteroids and what?
    Bjermer L; Diamant Z
    Curr Opin Pulm Med; 2009 Jan; 15(1):46-51. PubMed ID: 19077705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
    Peters S
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit-risk assessment of long-acting beta2-agonists in asthma.
    Jackson CM; Lipworth B
    Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating combination therapies for asthma: pros, cons, and comparative benefits.
    Bjermer L
    Ther Adv Respir Dis; 2008 Jun; 2(3):149-61. PubMed ID: 19124367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The place of long-acting beta 2 adrenergic agonists in the treatment of asthma and chronic obstructive lung disease (COPD)].
    van Schayck CP; Postma DS; Lammers JW
    Ned Tijdschr Geneeskd; 1999 Jan; 143(3):137-40. PubMed ID: 10086126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effectiveness of synergic therapy].
    Płusa T; Lubiński W
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():20-2. PubMed ID: 15524008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of long-acting beta-agonists in the treatment of asthma].
    Marti C; Janssens JP; Rutschmann O
    Rev Med Suisse; 2008 Oct; 4(175):2203-4, 2206-7. PubMed ID: 19024574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.